ReviewJournal of personalized medicine2025

Presepsin: An Emerging Biomarker in the Management of Cardiometabolic Disorders.

Dimitrios Kouroupis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.